COPD in perspective

Chest

Volumn 121, Issue 5 SUPPL., 2002, Pages 116S-120S

  Petty, Thomas L ^a  

^a NONE   (United States)

Author keywords

Chronic bronchitis; COPD; Definition; Emphysema; History; Oxygen therapy

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; EPHEDRINE; POTASSIUM IODIDE; THEOPHYLLINE; VASCULOTROPIN RECEPTOR;

AIRFLOW; AIRWAY OBSTRUCTION; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; HUMAN; LONG TERM EXPOSURE; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG RESECTION; NONHUMAN; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOKING CESSATION; SPIROMETRY; TREATMENT CONTRAINDICATION;

EID: 0036264597     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.5_suppl.116S     Document Type: Conference Paper

References (47)

1. On the capacity of the lungs, and on the respiratory movements, with a view of establishing a precise and easy method of detecting disease by the spirometer
2. Emphysema of the lungs (part II)
3. Clinical patterns of chronic bronchitis
4. Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions
5. Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema
6. The emphysematous and bronchial types of chronic airway obstruction: A clinopathological study of patients in London and Chicago
7. The functional and bronchographic evaluation of postmortem human lungs
8. Flow limitation during forced expiration in excised human lungs
9. Small airway pathology is related to increased closing capacity and abnormal slope of phase III in excised human lungs
10. Cigarette smoking and the lungs: Relation to postmortem evidence of emphysema, chronic bronchitis, and black lung pigmentation
11. Site and nature of airway obstruction in chronic obstructive pulmonary disease
12. Elastic recoil changes in early emphysema
13. Small airway disease is associated with elastic recoil changes in excised human lungs
14. The relations between structural changes in small airways and pulmonary-function tests
15. Ductectasia: An asymptomatic pulmonary change related to age
16. Structural and inflammatory changes in COPD: A comparison with asthma
17. Mechanisms in COPD: Differences from asthma
18. Experimental emphysema
19. Symposium on emphysema and the "chronic bronchitis" syndrome
20. Pulmonary emphysema with special references to vascular changes
21. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
22. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema
23. Radial traction and small airways disease in excised human lungs
24. Mild emphysema is associated with reduced elastic recoil and increased lung size but not with air-flow limitation
25. The morphology and morphometry of small airways disease (relevance to chronic obstructive pulmonary disease)
26. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry
27. The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia
28. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: A clinical trial
29. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema
30. Home oxygen: A revolution in the care of advanced COPD
31. Pulmonary rehabilitation in chronic respiratory insufficiency: Pulmonary rehabilitation in perspective; historical roots, present status, and future projections
32. 1: The Lung Health Study
33. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease
34. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease: International COPD Study Group
35. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
36. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking: European Respiratory Society Study on chronic obstructive pulmonary disease
37. Randomized, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
38. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive lung disease
39. Altered exercise gas exchange and cardiac function in patients with mild chronic obstructive pulmonary disease
40. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
41. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
42. Chronic obstructive pulmonary disease
43. Genetic risk factors for chronic obstructive pulmonary disease
44. New therapies for chronic obstructive pulmonary disease